What is Adverum Biotechnologies Inc Annual Revenue?

Adverum Biotechnologies Inc Annual Revenue fell 72.22%, in the last year to $1 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Adverum Biotechnologies Inc Annual Net Profit?

Adverum Biotechnologies Inc Annual Net Profit fell 7.22% in the last year to $130.93 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Adverum Biotechnologies Inc Price to Earning Ratio?

Adverum Biotechnologies Inc Price to Earning Ratio is -0.34, which is negative.

What is Adverum Biotechnologies Inc Stock Price?

Adverum Biotechnologies Inc Stock Price fell 73.63% and underperformed its sector by 82.49% in the past year.

What is Adverum Biotechnologies Inc Quarterly Net profit?

Adverum Biotechnologies Inc Quarterly Net profit fell 111.16% YoY to $60.53 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Adverum Biotechnologies Inc Debt to Equity Ratio?

Adverum Biotechnologies Inc Debt to Equity Ratio of 1.3 is higher than 1. This implies that company assets are financed through debt.

What is Adverum Biotechnologies Inc Return on Equity(ROE)?

Adverum Biotechnologies Inc Return on Equity(ROE) for the last financial year was -189.84%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Adverum Biotechnologies Inc Mutual Fund Holding?

Adverum Biotechnologies Inc Mutual Fund Holding decreased by 6.43% in the last quarter to 24.49.

What is Adverum Biotechnologies Inc Promoter Share Holding?

Adverum Biotechnologies Inc Promoter Share Holding decreased by 1.43% in the most recent quarter to 1.1%.

What is Adverum Biotechnologies Inc Institutional Holding?

Adverum Biotechnologies Inc Institutional Holding increased by 1.67% in the last quarter to 66.16.

Adverum Biotechnologies Inc XNAS: ADVM

Adverum Biotechnologies Inc Live Share Price Today, Share Analysis and Chart

Name: Adverum Biotechnologies Inc: Is Infosys Ltd. worth buying?
Item: Adverum Biotechnologies Inc
Rating: 0.75733325
Author: Trendlyne DVM scores

about

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustaine...

2.12 0.07 (3.41%)

New 52W Low in past week

391.7K XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

15.8 / 100

Technically Bearish

14.5 / 100

23

1Yr Price target upside is 985%

5 analysts

Adverum Biotechnologies Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adverum Biotechnologies Inc FAQ

How is Adverum Biotechnologies Inc today?

Adverum Biotechnologies Inc today is trading in the green, and is up by 3.41% at 2.12.

How has Adverum Biotechnologies Inc performed historically?

Adverum Biotechnologies Inc is currently trading up 3.41% on an intraday basis. In the past week the stock fell -24.56%. stock has been down -52.47% in the past quarter and fell -73.63% in the past year. You can view this in the overview section.